Bupropion HCl ER (extended-release) 

Bupropion HCl ER (extended-release) 
BUPROTROP SR 150 is a medication that is primarily used to treat depression and seasonal affective disorder (SAD), as well as to aid smoking cessation. BUPROTROP SR 150  is sold under several brand names, including Wellbutrin and Zyban.
BUPROTROP SR 150  is an antidepressant medication that works by affecting the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine. The extended-release formulation allows for a slower release of the medication over time, BUPROTROP SR 150  can help to reduce potential side effects and provide more consistent levels of the medication in the body.
The starting dose of BUPROTROP SR 150  once daily, which can be increased gradually under the supervision of a healthcare provider based on the individual's response to treatment. Common side effects of bupropion may include dry mouth, headache, insomnia, and nausea. Rare but serious side effects may include seizures, suicidal thoughts or behavior, and severe allergic reactions.
As with any medication, BUPROTROP SR 150  is important to speak with a healthcare provider to determine whether BUPROTROP SR 150  is an appropriate treatment option for a particular individual and to discuss any potential risks and benefits. BUPROTROP SR 150  may interact with other medications, so it is important to disclose all medications and supplements being taken to the healthcare provider.
For further information please contact:
info@sterispharma.com